Biotech News
Related news
HYPRHyperfine2026-08-06 20:05 EST
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
SGHTSight Sciences2026-08-04 21:38 EST
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System
HYPRHyperfine2026-07-30 12:15 EST
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
ANGOAngioDynamics2026-06-17 12:30 EST
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
AORTArtivion2026-06-29 11:00 EST
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
ICCMIceCure Medical2026-07-29 12:25 EST
IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
ICCMIceCure Medical2026-07-06 12:11 EST
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
ADPTAdaptive Biotechnologies2026-06-30 12:30 EST
Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial
PRCTPROCEPT BioRobotics2026-05-28 12:00 EST
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
NEPHNephros2026-07-06 11:00 EST
Nephros Announces Inclusion in the Russell Microcap® Index
Hyperfine
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...
Recent company news
HYPRHyperfine2026-08-06 20:05 EST
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
HYPRHyperfine2026-07-30 12:15 EST
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
HYPRHyperfine2026-07-23 20:05 EST
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
HYPRHyperfine2026-07-01 12:15 EST
Hyperfine Announces European Launch of Next-Generation Swoop® System
HYPRHyperfine2026-06-22 12:15 EST
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
Stock data
- Close
- 0.98 USD
- Market cap
- 148.91M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States